Discover our new @BIOASTER publication in @NatureProtocols.

A droplet #microfluidics technology has been developed to measure #proteinsecretion kinetics from #singlecells. This technology has been successfully used to characterize monocyte anergy in septic shock patients. SharedIt link   

For a new kind of fight

A Covid-19 learning By Nathalie Garçon, CEO/CSO BIOASTER   The current crisis reminds us today of the absolute and universal need to prepare in advance for such epidemics, which no...

BIOASTER COVID-19 INFORMATION

We are going through a major and unprecedented crisis, which involves drastically rethinking our lifestyles and work to slow down the epidemic, which is now ubiquitous, allow our health system...

Enterome collaborates with BIOASTER Institute

Enterome collaborates with BIOASTER Institute to provide new insights into mechanisms of potential microbiome-derived cancer immunotherapies ENTEROME SA, a clinical-stage biopharmaceutical company, and BIOASTER, the French Institute for Technological Research...
Post archive